Labcorp Holdings Inc.
Labcorp Holdings Inc. (LH) — Form 8-K: Current report
AI-generated summary
Labcorp Holdings Inc. filed a Form 8-K reporting on preliminary Clinical Laboratory Fee Schedule payment rates released by CMS. The company reaffirmed its 2026-2029 long-term outlook, which includes compound annual revenue growth between 5% and 8%. It also supports the RESULTS Act to address concerns regarding the preliminary payment cuts.
Key facts
- Item 7.01 · Regulation FD disclosure
More LH filings
- 10-Q
Filed Oct 30, 2026
- 144
Filed Oct 30, 2026
- 8-K
Filed Oct 28, 2026
- 8-K
Filed Oct 21, 2026
- 8-K
Filed Sep 30, 2026
- 8-K
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.